<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Epigenetics</journal-id>
<journal-id journal-id-type="iso-abbrev">Epigenetics</journal-id>
<journal-id journal-id-type="pmc">KEPI</journal-id>
<journal-title-group>
<journal-title>Epigenetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1559-2294</issn>
<issn pub-type="epub">1559-2308</issn>
<publisher>
<publisher-name>Taylor &amp; Francis</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26575259</article-id>
<article-id pub-id-type="pmc">4844233</article-id>
<article-id pub-id-type="publisher-id">1114202</article-id>
<article-id pub-id-type="doi">10.1080/15592294.2015.1114202</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Paper</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Maternal immune activation induces <italic>GAD1</italic> and <italic>GAD2</italic> promoter remodeling in the offspring prefrontal cortex</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Labouesse</surname>
<given-names>Marie Anaïs</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="an0001">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dong</surname>
<given-names>Erbo</given-names>
</name>
<xref ref-type="aff" rid="af0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grayson</surname>
<given-names>Dennis Robert</given-names>
</name>
<xref ref-type="aff" rid="af0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guidotti</surname>
<given-names>Alessandro</given-names>
</name>
<xref ref-type="aff" rid="af0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meyer</surname>
<given-names>Urs</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="af0003">
<sup>3</sup>
</xref>
</contrib>
<aff id="af0001"><label>1</label><institution>Physiology and Behavior Laboratory; ETH Zurich</institution>; Schwerzenbach, <country>Switzerland</country></aff>
<aff id="af0002"><label>2</label><institution>Psychiatric Institute, Department of Psychiatry; College of Medicine; University of Illinois at Chicago</institution>; Chicago, Illinois, <country>USA</country></aff>
<aff id="af0003"><label>3</label><institution>Institute of Pharmacology and Toxicology; University of Zurich-Vetsuisse</institution>; Zurich, <country>Switzerland</country></aff>
</contrib-group>
<author-notes>
<corresp id="an0001"><label>*</label>Correspondence to: Marie A Labouesse Email: <email xlink:href="marie-labouesse@ethz.ch">marie-labouesse@ethz.ch</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>11</month>
<year>2015</year>
</pub-date>
<volume>10</volume>
<issue>12</issue>
<fpage seq="6">1143</fpage>
<lpage>1155</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>9</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>21</day>
<month>10</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>10</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>© 2015 Taylor &amp; Francis Group, LLC</copyright-statement>
<copyright-year>2015</copyright-year>
<copyright-holder>Taylor &amp; Francis Group, LLC</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="kepi-10-12-1114202.pdf"></self-uri>
<abstract>
<p>Maternal infection during pregnancy increases the risk of neurodevelopmental disorders in the offspring. In addition to its influence on other neuronal systems, this early-life environmental adversity has been shown to negatively affect cortical γ-aminobutyric acid (GABA) functions in adult life, including impaired prefrontal expression of enzymes required for GABA synthesis. The underlying molecular processes, however, remain largely unknown. In the present study, we explored whether epigenetic modifications represent a mechanism whereby maternal infection during pregnancy can induce such GABAergic impairments in the offspring. We used an established mouse model of prenatal immune challenge that is based on maternal treatment with the viral mimetic poly(I:C). We found that prenatal immune activation increased prefrontal levels of 5-methylated cytosines (5mC) and 5-hydroxymethylated cytosines (5hmC) in the promoter region of <italic>GAD1</italic>, which encodes the 67-kDa isoform of the GABA-synthesising enzyme glutamic acid decarboxylase (GAD67). The early-life challenge also increased 5mC levels at the promoter region of <italic>GAD2</italic>, which encodes the 65-kDa GAD isoform (GAD65). These effects were accompanied by elevated <italic>GAD1</italic> and <italic>GAD2</italic> promoter binding of methyl CpG-binding protein 2 (MeCP2) and by reduced GAD67 and GAD65 mRNA expression. Moreover, the epigenetic modifications at the <italic>GAD1</italic> promoter correlated with prenatal infection-induced impairments in working memory and social interaction. Our study thus highlights that hypermethylation of <italic>GAD1</italic> and <italic>GAD2</italic> promoters may be an important molecular mechanism linking prenatal infection to presynaptic GABAergic impairments and associated behavioral and cognitive abnormalities in the offspring.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>Autism</kwd>
<kwd>chromatin</kwd>
<kwd>DNA methylation</kwd>
<kwd>epigenetics</kwd>
<kwd>GABA, maternal infection</kwd>
<kwd>poly(I:C)</kwd>
<kwd>prefrontal cortex</kwd>
<kwd>prenatal immune activation</kwd>
<kwd>schizophrenia</kwd>
</kwd-group>
<counts>
<fig-count count="7"></fig-count>
<table-count count="2"></table-count>
<ref-count count="85"></ref-count>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>